Microinnova at the PHARMECO Consortium Event

6. October 2026 |
General | News | R&D

Industry leaders, academic pioneers, and regulatory experts gathered for the latest PHARMECO Consortium event in Stockholm. As a proud partner in this multi-million-euro initiative, our team is excited to connect with our European collaborators to drive forward the next generation of sustainable pharmaceutical manufacturing.

Triggering a Green Revolution in Pharma

The healthcare sector is responsible for up to 8% of CO₂ emissions in OECD countries, relying heavily on massive quantities of water, solvents, and fossil-based raw materials. Supported by the Innovative Health Initiative (IHI JU), the PHARMECO project was launched to change this paradigm.

Our Role: Scaling Continuous Flow Chemistry

At Microinnova, we specialize in transitioning chemical processes from lab tests to highly efficient, tons-per-hour production using modular continuous plants.

Within the PHARMECO framework, we are dedicating our engineering expertise to Work Package 6 (WP6). Our focus includes:

 

  • Scale-up: Scaling continuous processes leveraging our advanced flow chemistry technology.
  • Modular Engineering: Specialized plant engineering to ensure that the new green process technologies can be practically and economically implemented at an industrial scale.

 

On September 24th, the transfer workshop between WP3 (Development) and WP6 (Scale-up) took place. The workshop explored lab-to-commercial scaling methodologies based on a Sanofi initiative, utilizing a capability versus demand matrix to identify developmental gaps across multi-purpose standard, photochemical, and continuous crystallization platforms. Additionally, the session featured a dedicated deep dive into continuous crystallization, fostering collaborative discussions with Sanofi, RCPE, and AstraZeneca to outline equipment and team requirements for a future case study. Dr. Dirk Kirschneck co-facilitated an interactive workshop where he explored the strategic integration of Module Type Package (MTP) automation protocols within the PHARMECO framework.

PHARMECO: Collaborating with the Best

Transforming an entire industry requires a united front. For this event we are collaborating with an incredible roster of partners:  AbbVie, AIMPLAS · Technological Institute of Plastics, AstraZeneca, Benkei, BIOTOOLOMICS LIMITED, Boehringer Ingelheim, CPI, CULTZYME, Ghent University (CESPE), GSK, Johnson & Johnson, LifeClean International AB, Loughborough University, Medtronic, Merck Group, Novo Nordisk, Pfizer, Radboud University, RCPE – Research Center Pharmaceutical Engineering GmbH, RISE Research Institutes of Sweden (Nikolaas Schipper), RIVM National Institute for Public Health and the Environment, Sanofi (Lana Borukhova & Bruno Baillon), Servier, SFE Process, SwiftPharma, Technische Universität Berlin, UCB, University of Graz, VTU Group

As we sit down with our WP leaders and early-stage researchers, the focus is on aligning our continuous processing capabilities with the broader sustainability assessments and digital decision-making tools being developed by the consortium.

Stay tuned for more updates as we continue to engineer a greener, more sustainable future for pharmaceutical manufacturing.